Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods for using macrocyclic lactone compounds as multidrug resistance reversing agents in tumor and other cells

Methods for using macrocyclic lactone compounds as multidrug resistance reversing agents in tumor and other cells

US Patent 6114376 · Granted Sep 5, 2000

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Markers to predict macrocyclic lactone drug resistance in Dirofilaria immitis, t2025
Markers to predict macrocyclic lactone drug resistance in Dirofilaria immitis, t2022
Use of avermectin derivative for increasing bioavailability and efficacy of macr2021
Use of avermectin derivative for increasing bioavailability and efficacy of macr2021
Patient-specific temporary implants for accurately guiding local means of tumor 2019
Markers to predict macrocyclic lactone drug resistance in dirofilaria immitis, t2018
Macrocyclic lactone resistance marker for dirofilaria immitis2014
Vimentin directed diagnostics and therapeutics for multidrug resistant neoplasti2010
Tissue diagnostics for breast cancer2010
Method and System for automated auditing of advertising2009
Vimentin directed diagnostics and therapeutics for multidrug resistant neoplasti2009
Nucleophosmin directed diagnostics and therapeutics for multidrug resistant neop2008